Clinical Trial Update: Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the combination of Copanlisib and Venetoclax for relapsed or refractory mantle cell lymphoma, currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Copanlisib (copanlisib)
• Venetoclax (venetoclax)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING